Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for pharmaceuticals
[Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision [Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision Reviewed by Jocelyn Bosse on Thursday, February 13, 2025 Rating: 5
Australian Full Court clarifies the meaning of "first approval" for the purpose of patent term extension (PTE) Australian Full Court clarifies the meaning of "first approval" for the purpose of patent term extension (PTE) Reviewed by Dr Rose Hughes on Tuesday, April 19, 2022 Rating: 5
‘Competition law in the pharmaceutical sector’ conference returns with IPKat readers’ discounted fee ‘Competition law in the pharmaceutical sector’ conference returns with IPKat readers’ discounted fee Reviewed by Eleonora Rosati on Tuesday, October 26, 2021 Rating: 5
New decision of the Swedish Patent and Market Court of Appeal addresses interface between new safety regulation for packaging of pharmaceuticals and parallel imports New decision of the Swedish Patent and Market Court of Appeal addresses interface between new safety regulation for packaging of pharmaceuticals and parallel imports Reviewed by Frantzeska Papadopoulou on Tuesday, October 01, 2019 Rating: 5
Public procurement of pharmaceuticals and the patent system, the first date of a stormy relationship? Public procurement of pharmaceuticals and the patent system, the first date of a stormy relationship? Reviewed by Frantzeska Papadopoulou on Thursday, October 04, 2018 Rating: 5
Surveying the scene - passing off & surveys Surveying the scene - passing off & surveys Reviewed by Rosie Burbidge on Saturday, February 17, 2018 Rating: 5

An Improved Improver? - Part 3

Having been distracted from the world of IP by his daughter's recent wedding, there has been some delay in this GuestKat's posting ...
- Thursday, August 10, 2017
An Improved Improver? - Part 3 An Improved Improver? - Part 3 Reviewed by Stephen on Thursday, August 10, 2017 Rating: 5
Intellectual Property Challenges in the Bio-Pharmaceutical Field Intellectual Property Challenges in the Bio-Pharmaceutical Field Reviewed by Mike Mireles on Wednesday, May 04, 2016 Rating: 5
Concentration isn't that hard - Methotrexate patent Accordingly found invalid Concentration isn't that hard - Methotrexate patent Accordingly found invalid Reviewed by Darren Smyth on Friday, January 15, 2016 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.